Myelodysplastic syndrome (MDS) is a rare haematological cancer characterized by abnormal development and maturation (dysplasia) of immature blood cells in the bone marrow, resulting in varying ...

Based Roundtable® event, Andrew M. Brunner, MD, discussed dosing strategy for erythropoiesis-stimulating agents as well as ...

Myelodysplastic syndromes (MDS) affect the way your body makes new red blood cells, white blood cells, and platelets. MDS treatments slow the disease, help relieve symptoms like tiredness and ...

Luspatercept significantly improved hemoglobin levels in non-transfusion-dependent patients with lower-risk myelodysplastic ...

The European Medicines Agency (EMA) has given a positive recommendation for Rytelo ( imetelstat) for the treatment of adult ...

Conventional parameters for risk stratification prognosis for patients with low-risk myelodysplastic neoplasms, especially ...

With a link to specific genetic mutations in myelodysplastic syndromes, tobacco smoking may be associated with disease progression and survival.

Venetoclax with hypomethylating agents produced better responses than HMAs alone in adult patients with myelodysplastic ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...

Wedbush analyst Yun Zhong has maintained their bullish stance on KROS stock, giving a Buy rating yesterday.Pick the best stocks and maximize ...